Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05611385 · ClinicalTrials.gov registry record
Amphetamine Induced Adult Respiratory Distress Syndrome
A clinical trial, sponsored by Arrowhead Regional Medical Center.
- Completed
- Registry status
- 49
- Enrollment target
NCT05611385: Completed study, sponsored by Arrowhead Regional Medical Center.
NCT05611385 is a clinical trial that has completed, run by Arrowhead Regional Medical Center. The registered enrollment target is 49 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05611385 has completed, sponsored by Arrowhead Regional Medical Center.
- COMPLETED
- Registry status
- 49 participants
- Enrollment target
Study Summary
Methamphetamine and amphetamine has various cardiovascular and central nervous system effects. Long-term use is associated with many adverse health effects including cardiomyopathy, hemorrhagic, and ischemic stroke. Death is usually caused by cardiovascular collapse and while amphetamine abuse has been considered as a potential cause of acute respiratory distress syndrome, the reports are usually anecdotal. This investigation considers reviewing individuals with few to zero medical conditions who develop acute respiratory distress syndrome and are methamphetamine positive
Primary Outcome
Documentation on admission of inhalation injury as defined by burned nasal hairs, burned facial skin, and carbonaceous sputum after admission to the hospital within the first 24 hours.
Interventions
- OTHER Difference in development of Acute Lung Injury in Amphetamine positive and negative patients
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2019-01-01 |
| Est. Completion | 2020-01-01 |
What the finished NCT05611385 record still lists
NCT05611385 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 49 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Difference in development of Acute Lung Injury in Amphetamine positive and negative patients is the first listed.
NCT05611385 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05611385 about?
NCT05611385 is a clinical study titled "Amphetamine Induced Adult Respiratory Distress Syndrome". Methamphetamine and amphetamine has various cardiovascular and central nervous system effects. Long-term use is associated with many adverse health effects including cardiomyopathy, hemorrhagic, and ischemic stroke. Death is usually caused by cardiovascular collapse and while amphetamine abuse has b...
What is the current status of trial NCT05611385?
This trial is currently completed. The enrollment target is 49 participants. The study started on 2019-01-01. Estimated completion is 2020-01-01.
What interventions are being tested in trial NCT05611385?
The interventions under investigation include: Difference in development of Acute Lung Injury in Amphetamine positive and negative patients (OTHER).
Who is sponsoring clinical trial NCT05611385?
This trial is sponsored by Arrowhead Regional Medical Center, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02704858 · 49 participants · Phase 1
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
- NCT03516708 · 49 participants · Phase 1
Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
- NCT03692429 · 49 participants · Phase 1
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
- NCT04329494 · 49 participants · Phase 1
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI